Biogen Idec Makes Hostile Bid To Acquire Facet Biotech For $14.50/shr In Cash – Update

(RTTNews) – Friday, biotechnology company Biogen Idec Inc. (BIIB) said that it has submitted a proposal to the board of industry peer Facet Biotech Corp. (FACT) to acquire all of the outstanding shares of Facet for $14.50 per share in cash. The offer

Leave a Reply